Futura Medical (FUM)

 

FUM Share PerformanceMore

52 week high63.00 06/03/17
52 week low21.65 11/10/17
52 week change -23.50 (-41.23%)
4 week volume18,550,649 23/12/17

Latest NewsMore

Futura reports publication of positive MED2002 data

Futura Medical has announced the publication of positive data from its phase II clinical trial of MED2002 in erectile dysfu...

Publication of Positive MED2002 Clinical Data

RNS Number: 9126A Futura Medical PLC 04 January 2018 For immediate release 4 January 2018 Futura Medical plc ("Futura" or "the Company") Publication of Positive MED2002 Clinical Data Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, is pleased to announce the publication of positive data fr...

Director/PDMR Shareholding

RNS Number: 8847A Futura Medical PLC 03 January 2018 3 January 2018 Futura Medical plc ("Futura" or "the Company") PDMR Dealing Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology has been notified that Rachael Hawken, a person discharging managerial responsibilities ("PDMR"), has sold 10,...

Remuneration of Non-Executive Directors and TVR

RNS Number: 7603A Futura Medical PLC 02 January 2018 For immediate release 2 January 2018 Futura Medical plc ("Futura" or "the Company") Remuneration of Non-Executive Directors and Total Voting Rights Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, announces the issue of 37,320 new o...

Recruitment starts for PK study, says Futura

Futura Medical has announced that recruitment has started for the company's pharmacokinetic study of MED2002, its no...

MED2002: PK Study Commences

RNS Number: 7852X Futura Medical PLC 29 November 2017 For immediate release 29 November 2017 Futura Medical plc ("Futura" or "the Company") MED2002: PK Study Commences Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, announces that recruitment has commenced for the Company...

MED2002: Regulatory, Clinical & Commercial Update

RNS Number: 7858X Futura Medical PLC 29 November 2017 For immediate release 29 November 2017 Futura Medical plc ("Futura" or "the Company") MED2002: Regulatory, Clinical and Commercial Update Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, announces the following update on the r...

Block Listing Update

RNS Number: 4913X Futura Medical PLC 24 November 2017 24 November 2017 Futura Medical plc ("Futura" or "the Company") Block Listing Update Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology makes the following update on its block listing, pursuant to AIM Rule 29 and Schedule Six of the A...

Fundamental DataMore

EPS-3.65
Dividend yield0 %

Latest discussion posts More

  • Re: Tony's Theory

    I don't think you are barking up the wrong tree Tony. The link you provided contains some information, but there is much I think that is not commented upon. "We have ...
    18-Jan-2018
    trump53
  • Re: Tony's Theory

    ****No more mention of chasing regional or global deals. I am coming quite obsessed with this and probably barking up the wrong tree. I need to get out more!***** Maybe ...
    18-Jan-2018
    Aberdeen_investor
  • Re: Tony's Theory

    Per FUM's website re MED ....... http://www.futuramedical.com/content/products/med_2002.asp ........... the section on commercialisation (apart from the Quantum Pharma ...
    18-Jan-2018
    TonyDeadeye

Users' HoldingsMore

Users who hold Futura Medical also hold..

Codes & Symbols

ISINGB0033278473
SymbolsFUM, LSE:FUM, FUM.L, FUM:LN, LON:FUM, XLON:FUM

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account